Aehr Test Systems (AEHR) VP Sporck reports insider stock sales

Rhea-AI Filing Summary

Aehr Test Systems officer Alistair N. Sporck reported selling company stock. On 02/09/2026, Sporck, VP Contactor Business Unit, sold 2,700 shares of common stock at $27.57 per share and 300 shares at $27.59 per share, leaving 25,153 shares held directly and 5,214 shares held indirectly by a trust, which include shares subject to unvested restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SPORCK ALISTAIR N

(Last) (First) (Middle)

C/O AEHR TEST SYSTEMS

400 KATO TERRACE

(Street)

FREMONT CA 94539

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP Contactor Business Unit

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		S		2,700	D	$27.57	25,453	D
Common Stock	02/09/2026		S		300	D	$27.59	25,153(1)	D
Common Stock								5,214	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The amount reported includes shares subject to unvested restricted stock units.

Remarks:

	/s/Chris Siu, Attorney-in-Fact	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who is the insider involved in this AEHR Form 4 filing?

The insider is Alistair N. Sporck, who serves as VP Contactor Business Unit at Aehr Test Systems. He is an officer but not a director or 10% owner, according to the reported relationships in the filing.

How many Aehr Test Systems (AEHR) shares did Alistair Sporck sell?

Alistair Sporck sold 2,700 shares of Aehr Test Systems common stock in one transaction and 300 shares in a second transaction, both dated 02/09/2026, as reported in Table I of the Form 4 filing.

At what prices were the AEHR shares sold by Alistair Sporck?

The reported sales were executed at $27.57 per share for 2,700 shares and $27.59 per share for 300 shares. These prices reflect the per-share transaction amounts disclosed for the 02/09/2026 trades.

How many AEHR shares does Alistair Sporck hold after the reported transactions?

Following the reported sales, Alistair Sporck directly owned 25,153 shares of Aehr Test Systems common stock. He also had an additional 5,214 shares held indirectly by a trust, as shown in the beneficial ownership columns.

What is the nature of Alistair Sporck’s indirect ownership of AEHR shares?

The filing shows 5,214 shares of Aehr Test Systems common stock held indirectly "By Trust". This indicates the shares are owned through a trust rather than directly, but are still reported as his beneficial ownership interest.

Do Alistair Sporck’s AEHR holdings include unvested restricted stock units?

Yes. A footnote explains that the reported amount includes shares subject to unvested restricted stock units. This means some of the beneficially owned shares are tied to awards that have not yet fully vested.